Systemic TGF-β overexpression has been shown to have an inhibitory effect in various autoimmune diseases, including spontaneous lupus nephritis [21], autoimmune encephalomyelitis [22], insulitis in NOD mice [23], and erosive arthritis [24]. This evidence concerns the gene TGFB1 and autoimmune disease.